References
  1. Ghazi AA, Attarian H, Attarian S, Abasahl A, Daryani E, Farasat E, Pourafkari M, Tirgari F, Ghazi SM, Kovacs K. Hypercalcemia and huge splenomegaly presenting in an elderly patient with B-cell non-Hodgkin’s lymphoma: a case report. J Med Case Rep. 2010 Oct 19;4:330.
  2. Abadi U, Peled L, Gurion R, Rotman-Pikielny P, Raanani P, Ellis MH, Rozovski U. Prevalence and clinical significance of hypercalcemia at diagnosis in diffuse large B-cell lymphoma. Leuk Lymphoma. 2019 Dec;60(12):2922-2926.
  3. Ravioli S, Lafranchi A, Exadaktylos AK, Haidinger M, Lindner G. Characteristics and outcome of severe hypercalcemia on admission to the emergency department: a retrospective cohort study. Swiss Med Wkly. 2023 Apr 20;153:40069.
  4. Mousseaux, C., Dupont, A., Rafat, C. et al.  Epidemiology, clinical features, and management of severe hypercalcemia in critically ill patients. Ann. Intensive Care  9 , 133 (2019).
  5. Walker MD, Shane E. Hypercalcemia: A Review. JAMA 2022; 328:1624.
  6. Gauchy AC, Kanagaratnam L, Quinquenel A, Gaillard B, Rodier C, Godet S, Delmer A, Durot E. Hypercalcemia at diagnosis of diffuse large B-cell lymphoma is not uncommon and is associated with high-risk features and a short diagnosis-to-treatment interval. Hematol Oncol. 2020 Aug;38(3):326-333.
  7. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues (Revised 4th Edition) . Lyon, France: International Agency for Research on Cancer; 2017: 585.
  8. Romano A, Giusti M, Di Giorgio M, Lumera G, Laura Parrinello N, Cosentino S, Ippolito M, Villari L, Alberto Palumbo G, Di Raimondo F, Santo Signorelli S. The first description of a singular case of synchronous chronic myelomonocytic leukemia and diffuse large b-cell lymphoma. Clin Case Rep. 2021 Sep 21;9(9):e03817.
  9. Valent P, Orazi A, Savona MR, et al. Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre‐CMML conditions. Haematologica . 2019;104(10):1935‐1949